Part One of Coventry’s 2017 Drug Trends Series reported the largest drop in Morphine Equivalent Dose (MED) in the last three years. As an indicator of increased chances for adverse outcomes, including death from overdose, these and other inroads are essential in the effort to curtail opioid misuse. To learn more about MED and its impact watch our latest video blog.
More stories
What Really Drives P&C Policy Change: It’s Local
Ever wonder what really drives legislative decisions, and why some seemingly “no-brainer” policies don’t pass? We dig into the idea that all politics is local and what that actually looks like in practice, especially for those in the P&C space.
Driving Better Outcomes Through Total Program Integration
Explore how aligning telephonic case management and bill review helped reduce claim costs, improve efficiency, and deliver better outcomes.
What New State Health Care Proposals Could Mean for Workers' Comp and Auto
Single-payer healthcare proposals may affect workers’ comp and auto medical benefits. See what state bills could mean for P&C strategy planning today.
Catastrophic Claims Need a Lifetime Roadmap
A life care plan helps adjusters evaluate catastrophic claims with a defensible roadmap of lifetime medical needs, costs, and long-term exposure.
Building Resilience Through Crisis Intervention
Crisis intervention helps organizations respond to traumatic events, stabilize employees, and support recovery. Learn key approaches, benefits, and how to build resilience.
Ask The Pharmacist: What Work Comp Adjusters Should Know About New Generic Tapentadol
Generic versions of Nucynta are now available in the U.S. market. For workers’ compensation claims, this may create brand-to-generic conversion opportunities, especially as part of a longer-term pain regimen.